系统性红斑狼中血栓形成的分子机制 - 一个系统性审查
Mads L Larsen1, Laura Nørgaard2, Petrus Linge3
1Department of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Seminars in arthritis and rheumatism
|March 14, 2025
概括
系统性红斑狼 (SLE) 患者具有高血栓形成风险. 本综述确定了六种血栓形成机制,突出了自身抗体和补充系统作用的知识差距,并研究了更好地预防SLE血栓形成的研究设计.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性红斑狼 (SLE) 患者在诊断后面临~30%的血栓形成风险.
- 目前对SLE中血栓形成机制的理解尚不完整,缺乏具体的抗血栓指南.
研究的目的:
- 系统地审查导致SLE血栓形成风险的机制.
- 专注于自身抗体,补体系统,血小板,内皮和凝血系统.
主要方法:
- 按照PRISMA指南进行系统审查.
- 搜索了PubMed和Embase;包括30项研究 (28项高质量).
- 包括使用SLE患者血液样本的实验研究,一个动物和一个病例对照研究.
主要成果:
- 在SLE中确定了六种不同的血栓形成机制.
- 自体抗体,特别是抗脂抗体 (aPL),是最受研究的.
- 在aPL和其他自身抗体之间潜在的共享机制可能解释aPL阴性SLE中血栓形成.
- 关于补充系统的作用和前凝因因子之间的相互作用,存在重大知识差距.
结论:
- 自体抗体是导致SLE相关血栓形成的关键因素.
- 需要对补充系统和多种促凝因子相互作用进行进一步的研究.
- 前性研究对于推进SLE血栓形成的预防和个性化治疗策略至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586
Extrinsic and Intrinsic Pathways of Hemostasis
4.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.5K
Disorders of Hemostasis
674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674
Clot Retraction and Fibrinolysis
3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K


